First-Line Trodelvy Regimens Approved for Triple-Negative Breast Cancer
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Trodelvy regimens have been approved for use as a first-line treatment for triple-negative breast cancer. This approval is for use in this specific type of breast cancer. The treatment has been given the green light for patients with this condition.